Flynn, N.R.; Ward, M.D.; Schleiff, M.A.; Laurin, C.M.C.; Farmer, R.; Conway, S.J.; Boysen, G.; Swamidass, S.J.; Miller, G.P.
Bioactivation of Isoxazole-Containing Bromodomain and Extra-Terminal Domain (BET) Inhibitors. Metabolites 2021, 11, 390.
https://doi.org/10.3390/metabo11060390
AMA Style
Flynn NR, Ward MD, Schleiff MA, Laurin CMC, Farmer R, Conway SJ, Boysen G, Swamidass SJ, Miller GP.
Bioactivation of Isoxazole-Containing Bromodomain and Extra-Terminal Domain (BET) Inhibitors. Metabolites. 2021; 11(6):390.
https://doi.org/10.3390/metabo11060390
Chicago/Turabian Style
Flynn, Noah R., Michael D. Ward, Mary A. Schleiff, Corentine M. C. Laurin, Rohit Farmer, Stuart J. Conway, Gunnar Boysen, S. Joshua Swamidass, and Grover P. Miller.
2021. "Bioactivation of Isoxazole-Containing Bromodomain and Extra-Terminal Domain (BET) Inhibitors" Metabolites 11, no. 6: 390.
https://doi.org/10.3390/metabo11060390
APA Style
Flynn, N. R., Ward, M. D., Schleiff, M. A., Laurin, C. M. C., Farmer, R., Conway, S. J., Boysen, G., Swamidass, S. J., & Miller, G. P.
(2021). Bioactivation of Isoxazole-Containing Bromodomain and Extra-Terminal Domain (BET) Inhibitors. Metabolites, 11(6), 390.
https://doi.org/10.3390/metabo11060390